The listed company Huada Genomics is chasing the blockchain.
At 17:00 on March 30, among the first batch of domestic blockchain information service filing lists released by the Cyberspace Administration of China, Shenzhen Huada Gene Technology Co., Ltd. filed its Huada Blockchain BaaS platform.
At the 2018 China International Big Data Industry Expo (hereinafter referred to as "Digital Expo"), Huada Genomics announced its own Huada Blockchain BaaS platform for the first time and released a white paper.Yang Meng, who was in charge of Huada Blockchain at the time, once said that, through the application of blockchain technology to build a shared infrastructure for omics data, it will be able to promote the value flow of digital life on the premise of data security and privacy protection.
secondary title
"Internet celebrities" in the biomedical industry
From the earliest participation in the Human Genome Project, to the publication of a large number of academic papers, to the introduction of gene sequencing equipment to explore the gene technology to empower medicine and successfully landed. Huada Gene is indeed a "net celebrity" company in the biomedical industry.
According to public information, Huada Genomics was born in 1999 with the launch of the International Human Genome Project. Over the years, the company has been focusing on the field of life sciences and has cultivated a talent echelon.
Someone once commented that BGI has promoted the industrialization of biology, and also opened up the domestic genetic testing and bioinformatics industries.
In addition to the original Human Genome Project, BGI has indeed achieved considerable results in the application of genetic science. For example, it uses genetic testing to realize non-invasive prenatal diagnosis technology, and promotes large-scale application, providing a new solution for prenatal and postnatal care and reducing costs.
On July 5, 2017, after the successful IPO of Huada Gene, Huada Gene became a "monster stock" for a time.
Party A Research Institutesecondary title
Boasting that Haikou wants employees to live to 100 years old, it is in crisis of information leakage
The good times of Huada Gene's stock price rising did not last long.
BGI Chairman Wang Jian's many wonderful quotations have aroused the negative emotions of shareholders.
On May 28, 2018 at the Data Expo, Wang Jian shared several regulations on employees in the company. Cardiovascular and cerebrovascular diseases", "Employees want to live to 100 years old". The stock price of Huada Gene fell sharply that day, almost cut in half.
Subsequently, in several public occasions, Wang Jian also repeatedly released the "confidence" quotations of "It is better to have a genetic test every three years than to get a cervical cancer vaccine" and "Any life can be chemically synthesized within 10 years". Once pushed to the forefront of public opinion, people became very curious about the leader Wang Jian. Some people commented that Wang Jian is a genetic madman and a marketing master.At that time, the media dug up, Wang Jian once made a tombstone for himself, and the time of his death is 2074. Calculated, Wang Jian was already 120 years old when he "died".
Then, BGI fell into an information leakage crisis.
In 2018, BGI published a large-scale genetic testing data research result in the international academic journal "Cell", which involved the genetic data of 140,000 Chinese. This incident was later questioned as handing over relevant data to overseas institutions without government permission. The Shenzhen Stock Exchange inquired about this, and BGI responded: "140,000 Chinese genetic big data" project has no foreign partner institutions.
Coincidentally, while the negative public opinion about the outflow of genetic data has not subsided, the performance of Huada Gene is also declining. In 2018, the performance sheets submitted by BGI for the first three quarters and the third quarter were lower than market expectations.
The 2018 annual performance bulletin released by Huada Gene this year shows that compared with 2017, the company's operating profit fell by 0.64%, and the basic earnings per share fell by 3.81%.
At present, Huada Genomics is classified into hidden in vitro diagnostics, biomedicine, Shenzhen Stock Connect, gene sequencing, healthy China, medical device concepts, MSCI expectations, and blockchain. The concept of blockchain was added on April 1. . On March 30 this year, after the Internet Information Office announced the list of filing information services, Huada Gene's stock price once showed signs of rapid recovery.
secondary title
What exactly does Huada Blockchain BaaS do?
In fact, BaaS platforms are not uncommon in the blockchain world.
The full name of BaaS is Blockchain as a Service, which translates to "Blockchain as a Service". A previously launched by OdailyBlockchain BaaSAccording to the analysis in the research report, the BaaS platform embeds the blockchain framework into the cloud computing platform, and uses the deployment and management advantages of the cloud service infrastructure to provide developers with a convenient and high-performance blockchain ecological environment and ecological supporting services, supporting An open blockchain platform for developers' business development and operational support.
The BaaS platform is also the direction that large companies are keen to explore when they enter the blockchain. At present, BAT among the domestic Internet giants BATJ has developed its own BaaS platform. The BaaS platform also focuses more on a certain segmented field, such as finance, copyright, and traceability, which are all popular fields for BaaS service providers.
The difference is that BGI’s BaaS platform focuses more on the healthcare field.
In the Huada Blockchain channel on the official website of Huada Genomics, a white paper written by the Huada Blockchain project team was published.
According to the white paper, BGI has been deploying blockchain technology applications since 2018, and joined Hyperledger (Hyperledger, an open source project initiated by the Linux Foundation to promote blockchain digital technology and transaction verification) . BGI said it wanted to build a blockchain-based production-level infrastructure for data circulation.
At present, BGI's blockchain applications are mostly in the field of health care. In the field of health and medical care, data collection, storage and sharing have always had pain points such as easy data leakage, difficult sharing, and indeterminate rights. Whether it is health care or genetic technology, if you want to achieve leapfrog development, you must do a lot of research on data and samples. In the current environment, cross-institutional data sharing of medical data is also one of the problems that need to be solved urgently.
Simply put, BGI wants to use the blockchain to solve these three things:
One is to confirm the rights of personal life data and capitalize data resources to realize personal data autonomy;
The second is to use the blockchain to meet more secure data sharing and realize the safe sharing and exchange of data among various institutions;
The third is to avoid the overall collapse of the database caused by a single point of failure through the distributed storage technology of the blockchain, reduce data leakage accidents caused by centralized storage, and improve data security
The application of blockchain in medical institutions is not uncommon. Most medical institutions mainly use private chains or alliance chains, and large-scale blockchain applications have not yet been formed.
It is not easy to build a large-scale cross-institutional health and medical data sharing ecosystem. For a single medical institution, building a system from scratch is costly, requires a lot of investment, and there are certain technical barriers.
Odaily has also analyzed before,The development of a BaaS platform not only requires high R&D expenses and a large amount of hardware expenses, but also has a strong dependence on technology updates. Only large companies and high-income companies can afford it. Whether it is domestic or foreign, BaaS is almost always provided by Business giants take control.
secondary title
Huada Blockchain BaaS has been put into use
In response to the Huada blockchain BaaS platform, Odaily asked Huada Gene for verification. Wu Zongze, deputy director of investor relations of Huada Gene, revealed that the blockchain BaaS platform is a business of a non-listed company that Huada Group is doing. The Group's blockchain BaaS application is still in the R&D and internal testing stages.
text
The official website also announced 5 application examples of Huada blockchain BaaS, employee health data authorization incentive system, Changsha Maternal and Child Health Medical Alliance, rare disease multi-benefit collaboration system, etc.
In the employee health data authorization incentive system, BGI uses blockchain technology to securely share the life big data monitored by thousands of employees.
Through Huada Blockchain's blockchain-based data security sharing system, employees' data is returned to individuals, and the data has real value. Employees can sign up through the APP front-end and participate in some data recruitment projects. After contributing personal data, employees can get health points incentives. The data user can call the user's personal health data only with the authorization of the user.
Its official website revealed that the blockchain-based data interaction model has been applied to the internal cross-omics data employee health plan and the external tumor care plan.
In the Changsha Maternal and Child Health Medical Consortium system, BGI connects the nodes of various institutions on the Changsha Maternal and Child Health Platform to the Huada blockchain BaaS platform, and safely shares genetic screening and diagnostic data among institutions. .
In the multi-benefit collaboration system for rare diseases, BGI has joined hands with BGI to create a rare disease gene resource sharing platform to promote multi-party collaboration on the premise of ensuring the safety and privacy protection of genetic data of patients with rare diseases, and to promote the research on rare diseases. Research.
Even if multiple use cases have been made public, can BGI alone swallow the sweet pastry of "blockchain + gene technology" and "blockchain + health care"?
In fact, there are not many teams currently doing the same blockchain exploration. Nebula, gene value chain HGBC, Healio, etc. previously reported by Odaily are all exploring the possibility of blockchain + gene sequencing.
Regarding the possibility of blockchain + gene sequencing, the HGBC team analyzed that the current medical field has gradually moved towards precision medicine, which is inseparable from accurate data, and gene sequencing plays an important role in the current targeted therapy of tumors, immunotherapy, etc. role. Joining the blockchain, in addition to constructing a safe and credible shared environment, the blockchain also allows everyone to truly control their own health data, and has incentives to contribute their own data, so that more real data will be used. in future medical research.
Regarding the layout of Huada blockchain BaaS, some insiders commented to Odaily that it is currently only used within the enterprise, and whether it can be promoted to the public remains to be seen.
